 | Study programme 2021-2022 | Français | |
 | Faculty of Medicine and Pharmacy | ||
| Master's in Biomedical Sciences : Specialist Focus on Neuroscience (Mons) |
- Panel Chairperson : Jean-Marie COLET
- Panel Secretary : Laurence RIS
| Show AAs | |||||||||||||||||
| Bloc 1 | Hours (*) | Term | Credits | Weight. | |||||||||||||
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | ||||||||||||
| Enseignements obligatoires communs | 10 | ||||||||||||||||
 UM-M1-BIOMED-016-M Scientific Redaction & Communication | 15 | 0 | 220 | 0 | 0 | 235 | Q2 | 10 | 10 | ||||||||
| Enseignements optionnels communs | 26 | ||||||||||||||||
L'étudiant de la finalité approfondie choisit des unités d'enseignement pour un total de 26 crédits.
L'étudiant de la finalité spécialisée en neuroscience choisit des unités d'enseignement pour un total de 30 crédits.
L'étudiant choisira un ensemble cohérent d'unités d'enseignement parmi l'offre de formation à option en fonction de son origine et de la couleur qu'il souhaite donner à son master.
Le jury de master validera l'adéquation des unités d'enseignement choisies.
Attention: 16 crédits maximum pourront être choisis dans la langue mineure du master. | |||||||||||||||||
| UM-M1-BIOMED-003-M Comparative Physiology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-008-M Animal Testing Training | 68 | 12 | 0 | 0 | 0 | 80 | Q1 | 8 | 8 | ||||||||
UM-M1-BIOMED-017-M Molecular & Cellular Biology of Cancer  | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-018-M Preclinical Models in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-019-M Nuclear Receptor in Oncology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-020-M Eléments d'immunologie clinique et expérimentale | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-021-M Histologie des organes des sens | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-022-M Neuropharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| UM-M1-BIOMED-023-M Voies intracellulaires de communication et maladies métaboliques | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-025-M Pharmacologie spéciale | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 | ||||||||
| UM-M1-BIOMED-026-M Méthodes de ciblage moléculaire et applications biomédicales de l'imagerie moléculaire | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 | ||||||||
| UM-M1-BIOMED-027-M Techniques d'imagerie médicale: principe et applications | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 | ||||||||
| UM-M1-BIOMED-028-M Integrative Biomedicine | 41 | 0 | 0 | 0 | 0 | 41 | Q1 | 6 | 6 | ||||||||
| UM-M1-BIOMED-029-M Research Techniques in Neuroscience | 45 | 0 | 0 | 0 | 0 | 45 | Q1 | 6 | 6 | ||||||||
| UM-M1-BIOMED-030-M Interdisciplinary Program in Healthcare Innovation | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 5 | 5 | ||||||||
| UM-M1-BIOMED-037-M Virologie | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-038-M Tools to analyse brain function | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 | ||||||||
| UM-M1-BIOMED-040-M Introduction to Coding | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-041-M Drugs & Strategies for Cancer Treatment | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-042-M Laboratory Methods in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| Enseignements complémentaires dédiés aux étudiants "passerelles" | 0 | ||||||||||||||||
| UM-M1-BIOMED-024-M Neuroanatomie et sémiologie neurologique | 36 | 15 | 0 | 0 | 0 | 51 | Q1 | 4 | 4 | ||||||||
| UM-M1-BIOMED-013-M Anatomie pathologique générale | 20 | 10 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 | ||||||||
| UM-M1-BIOMED-014-M Travaux personnels | 0 | 0 | 10 | 0 | 0 | 10 | Q1 | 5 | 5 | ||||||||
| UM-M1-BIOMED-015-M Stage en laboratoire | 0 | 0 | 40 | 0 | 0 | 40 | Q1 | 5 | 5 | ||||||||
| UM-M1-BIOMED-031-M Biochimie métabolique | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 3 | 3 | ||||||||
| UM-M1-BIOMED-032-M Pharmacologie générale | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-033-M Neurophysiologie des systèmes | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M1-BIOMED-034-M Biologie moléculaire | 30 | 0 | 0 | 0 | 0 | 30 | Q2 | 3 | 3 | ||||||||
| UM-M1-BIOMED-035-M Biologie cellulaire | 15 | 15 | 0 | 0 | 0 | 30 | Q2 | 2 | 2 | ||||||||
| UM-M1-BIOMED-039-M Biochimie générale | 30 | 10 | 0 | 0 | 3 | 43 | Q2 | 4 | 4 | ||||||||
| Enseignements obligatoires spécifiques à la finalité spécialisée en neuroscience | 20 | ||||||||||||||||
| UM-M1-BIOMFS-002-M Experimental Behavioral Neuroscience | 0 | 0 | 80 | 0 | 0 | 80 | Q1 | 6 | 6 | ||||||||
| UM-M1-BIOMFS-003-M Experimental Work in Neuroscience | 0 | 0 | 360 | 0 | 0 | 360 | Y | 10 | 10 | ||||||||
| UM-M1-BIOMFS-004-M Brain Plasticity | 10 | 20 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| 56 | |||||||||||||||||
| Bloc 2 | Hours (*) | Term | Credits | Weight. | |||||||||||||
| HT(*) | HTPE(*) | HTPS(*) | HD(*) | HR(*) | Total | ||||||||||||
| Enseignements obligatoires communs | 40 | ||||||||||||||||
| UM-M2-BIOMED-007-M Master Thesis | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 19 | 19 | ||||||||
| UM-M2-BIOMED-008-M External Training | 0 | 0 | 360 | 0 | 0 | 360 | Q2 | 21 | 21 | ||||||||
| Enseignements optionnels communs | 14 | ||||||||||||||||
L'étudiant de la finalité approfondie choisit des unités d'enseignement pour un total de 14 crédits.
L'étudiant de la finalité spécialisée en neuroscience choisit des unités d'enseignement pour un total de 10 crédits.
Il est également possible de choisir des unités d'enseignements parmi les enseignements optionnels communs du bloc 1. | |||||||||||||||||
| UM-M2-BIOMED-001-M GMP-GLP-Validation | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-002-M Intellectual Property | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-003-M Management Awareness of Technological Innovation Projects | 32 | 0 | 10 | 0 | 0 | 42 | Q1,Q2 | 4 | 4 | ||||||||
UM-M2-BIOMED-011-M Neurotoxicology & Safety Pharmacology  | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| UM-M2-BIOMED-012-M Molecular & Cellular Biology of Cancer | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-013-M Preclinical Models in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-014-M Nuclear Receptor in Oncology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-015-M Eléments d'immunologie clinique et expérimentale | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-016-M Histologie des organes des sens | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-017-M Neuropharmacology | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| UM-M2-BIOMED-018-M Voies intracellulaires de communication et maladies métaboliques | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-019-M Pharmacologie spéciale | 15 | 0 | 10 | 0 | 0 | 25 | Q1,Q2 | 2 | 2 | ||||||||
| UM-M2-BIOMED-020-M Méthodes de ciblage moléculaire et applications biomédicales de l'imagerie moléculaire | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 | ||||||||
| UM-M2-BIOMED-021-M Techniques d'imagerie médicale: principe et applications | 22 | 0 | 10 | 0 | 0 | 32 | Q1,Q2 | 3 | 3 | ||||||||
| UM-M2-BIOMED-022-M Integrative Biomedicine | 41 | 0 | 0 | 0 | 0 | 41 | Q1 | 6 | 6 | ||||||||
| UM-M2-BIOMED-023-M Research Techniques in Neuroscience | 45 | 0 | 0 | 0 | 0 | 45 | Q1 | 6 | 6 | ||||||||
| UM-M2-BIOMED-026-M Virologie | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-027-M Tools to analyse brain function | 20 | 0 | 0 | 0 | 0 | 20 | Q2 | 3 | 3 | ||||||||
| UM-M2-BIOMED-028-M Introduction to Computational Neuroscience | 20 | 0 | 0 | 0 | 0 | 20 | Q1 | 3 | 3 | ||||||||
| UM-M2-BIOMED-029-M Basic Understanding of AI and BCI | 30 | 0 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| UM-M2-BIOMED-030-M Introduction to Coding | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-031-M Drugs & Strategies for Cancer Treatment | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| UM-M2-BIOMED-032-M Laboratory Methods in Cancerology | 15 | 0 | 0 | 0 | 0 | 15 | Q1 | 2 | 2 | ||||||||
| Enseignements obligatoires spécifiques à la finalité spécialisée en neuroscience | 10 | ||||||||||||||||
| UM-M2-BIOMFS-001-M Neuroscience in Society | 0 | 40 | 0 | 0 | 0 | 40 | Q1 | 6 | 6 | ||||||||
| UM-M2-BIOMFS-002-M Psychophysiological bases of diseases: a cognitive approach | 22 | 8 | 0 | 0 | 0 | 30 | Q1 | 4 | 4 | ||||||||
| 64 | |||||||||||||||||
(*) HT : Hours of theory - HTPE : Hours of in-class exercices - HTPS : hours of practical work - HD : HMiscellaneous time - HR : Hours of remedial classes. - Per. (Period), Y=Year, Q1=1st term et Q2=2nd term
Please note, the course titles given here are translations of the original titles and are provided in English for information only. In order to know in which language the course will be taught, please refer to the French page. There, the titles provided in French indicate that the course is taught in French and the titles provided in English indicate that the course is taught in English.